Yesterday
Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock? Zacks11:02 8-Jul-25
Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? Zacks10:41 8-Jul-25
In the last 7 days
Gilead Sciences Completes Long-Term Study on Filgotinib for Rheumatoid Arthritis TipRanks12:27 3-Jul-25
Gilead Sciences: A Mixed Bag of Opportunities and Risks The Motley Fool00:57 2-Jul-25
In the last month
Outrage of the Month: The Continuing Problem of Pharmaceutical Industry Payments to Physicians Public Citizen08:08 1-Jul-25
Gilead's rare liver drug lands fast-track tag in Korea as rival Ipsen circles approval Korea Biomedical Review04:53 1-Jul-25
Gilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know Zacks18:56 27-Jun-25
Gilead Sciences’ Promising Phase 3 Study on Triple Negative Breast Cancer TipRanks12:18 27-Jun-25
Gilead partners to advance novel oral oncology drug European Pharmaceutical Review10:27 27-Jun-25
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:07 27-Jun-25
Gilead Sciences Advances Pediatric HIV Treatment with Latest Study Update TipRanks12:13 26-Jun-25
Gilead Sciences and Kymera enter oncology partnership worth up to $750m PMLiVE07:33 26-Jun-25
Gilead Sciences (GILD) Stock Moves -1.18%: What You Should Know Zacks19:05 25-Jun-25
Kymera Inks CDK2 Deal With Gilead Scrip Pharma Intelligence18:04 25-Jun-25
GILD Dividend Yield Pushes Past 3% Nasdaq15:47 25-Jun-25
Gilead Sciences Advances Ulcerative Colitis Treatment with GS-1427 Study TipRanks12:17 25-Jun-25
Gilead Sciences’ Promising Phase 3 Study in Endometrial Cancer: A Potential Game-Changer? TipRanks12:17 25-Jun-25
Gilead partners with Kymera to develop novel cancer therapy Proactive Investors (US)11:47 25-Jun-25
Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies Benzinga09:59 25-Jun-25
Kymera signs $750m cancer deal with Gilead as Sanofi opts in pharmaphorum09:02 25-Jun-25
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to… Business Wire (Press Release)07:05 25-Jun-25
[Interview] HIV nears a cure -- but stigma still holds us back Korea Biomedical Review01:04 25-Jun-25
The Drug That Could Revolutionize the Fight Against H.I.V. The New Yorker06:07 24-Jun-25
Gilead’s Vemlidy secures expanded pediatric approval for chronic hepatitis B in Korea Korea Biomedical Review02:36 24-Jun-25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead… PR Newswire (Press Release)05:25 23-Jun-25
The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir STAT04:38 23-Jun-25
Revolutionary HIV preventive treatment approved in the US Bursa.ro17:03 22-Jun-25
HIV prevention drug lenacapavir gets FDA nod, nearly 100 per cent effective says experts The Week (India)07:21 22-Jun-25
US FDA approves twice-a-year HIV shot that could end daily pills The Financial Express08:39 21-Jun-25
FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag Benzinga08:06 20-Jun-25
“Hard to justify” $28 000 price tag for breakthrough HIV prevention treatment, says UN agency British Medical Journal07:59 20-Jun-25
Health activists pressure Gilead to drop price of anti-HIV jab Business Day23:05 19-Jun-25
FDA Approves Breakthrough HIV Drug, but It Could Be Hard to Access Discover Magazine18:15 19-Jun-25
Twice-a-year shot to prevent HIV could stop transmission — if people can get it The Zimbabwean15:39 19-Jun-25
Revolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA Approval IFLScience12:28 19-Jun-25
Gilead’s Yeztugo Gets US Approval For Twice-Yearly PrEP Scrip Pharma Intelligence12:16 19-Jun-25
FDA Approves New Injection For HIV Prevention Black Enterprise12:09 19-Jun-25
Why Gilead Sciences (GILD) is a Top Momentum Stock for the Long-Term Zacks11:03 19-Jun-25
FDA approves first twice-yearly injection that prevents HIV infection Fox News08:51 19-Jun-25
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it Daily Herald, Illinois07:33 19-Jun-25
Gilead Sciences’ twice-yearly HIV PrEP drug Yeztugo granted FDA approval PMLiVE07:25 19-Jun-25
US medication safety agency approves biannual preventive HIV shot AfricaNews06:31 19-Jun-25
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud… Fortune06:17 19-Jun-25
FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV Medicines Law & Policy06:12 19-Jun-25
Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it… Mint05:40 19-Jun-25
US approves promising preventive HIV treatment France 2405:28 19-Jun-25
Gilead Sciences’ Yeztugo receives approval from US FDA for HIV Pharmaceutical Technology05:24 19-Jun-25
STAT Plus: Gilead’s CEO on the approval of a powerful new drug to prevent HIV STAT04:38 19-Jun-25
US approves twice-yearly HIV shot Northwest Arkansas Democrat-Gazette04:24 19-Jun-25
US FDA approves Gilead's twice-yearly injection for HIV prevention The Telegraph, Calcutta03:40 19-Jun-25
Powerful twice-a-year HIV drug that could stop transmission approved The Independent02:57 19-Jun-25
Breakthrough: FDA Approves Injection to Prevent HIV ScienceAlert01:04 19-Jun-25
Gilead’s Greed Imperils Access to Newly FDA-Approved Breakthrough HIV Prevention Shot Health GAP (Press Release)18:24 18-Jun-25
Will Big Pharma Greed Consume Promise of 'HIV-Ending' Shot? Common Dreams18:23 18-Jun-25
FDA Approves “Breakthrough” HIV Drug Mother Jones18:04 18-Jun-25
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials NBC Connecticut18:00 18-Jun-25
HIV advance: Twice-yearly shot to prevent infection New Zealand Herald17:40 18-Jun-25
Gilead's twice-yearly HIV prevention injection gets FDA approval Yahoo! US17:39 18-Jun-25
FDA Approves ‘Breakthough’ Drug to Prevent HIV Gizmodo17:31 18-Jun-25
Twice-a-year shot to prevent HIV approved by FDA – could stop transmission if people can get it Chicago Sun-Times17:23 18-Jun-25
Twice-a-year shot to prevent HIV approved in U.S. CBC.ca17:21 18-Jun-25
Gilead's twice-yearly PrEP drug is cleared by FDA pharmaphorum17:10 18-Jun-25
HIV prevention drug hailed as a 'breakthrough' gets FDA approval NPR17:07 18-Jun-25
US FDA approves Gilead's twice-yearly injection to prevent HIV GMA News16:52 18-Jun-25
FDA Approves Twice-Yearly Shot for HIV Prevention Medpage Today16:46 18-Jun-25
Gilead wins FDA approval for twice-yearly HIV prevention jab Financial Mail16:26 18-Jun-25
Gilead’s twice-yearly PrEP injection wins FDA approval, analysts see solid launch ahead Proactive Investors (US)15:50 18-Jun-25
US approves Gilead's twice-yearly injection to prevent HIV France 2415:33 18-Jun-25
FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis Pharmacy Times15:25 18-Jun-25
FDA approves twice-yearly shot of Gilead drug for HIV prevention BioPharma Dive15:13 18-Jun-25
FDA approves the world's only twice-a-year shot to prevent HIV Yahoo! UK & Ireland14:58 18-Jun-25
Gilead’s Twice-a-Year HIV Prevention Shot Wins FDA Approval (2) Bloomberg Law14:56 18-Jun-25
Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV American Journal of Managed Care14:54 18-Jun-25
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6… Business Wire (Press Release)14:49 18-Jun-25
STAT Plus: Gilead won U.S. approval for HIV prevention shot, but when will low-income countries … STAT14:28 18-Jun-25
Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report Benzinga14:58 17-Jun-25
Cutaneous Lupus Erythematosus Market Research Report 2025-2035, Competitive Analysis of Biogen, … Business Wire (Press Release)10:49 17-Jun-25
Gilead Sciences: Strong Buy On Pipeline Momentum And Cost Discipline Seeking Alpha14:32 15-Jun-25
Inside the 2025 Native Son Awards: A Stylish Reclamation of Black Queer Legacy Vogue18:52 12-Jun-25
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks10:03 12-Jun-25
Gilead’s Trodelvy wins Korean coverage for breast cancer -- too late for some and still off-limits up front Korea Biomedical Review20:29 11-Jun-25
In Brief: Gilead HIV Trials On Hold Over Safety Signal Scrip Pharma Intelligence05:37 11-Jun-25
Why Gilead Scinces Stock Tumbled on Tuesday The Motley Fool00:26 11-Jun-25
Drug Cos. Face Persistent Scrutiny Over Physician Kickbacks Law36015:18 10-Jun-25
Market movers: Gilead, eToro, Insmed, Northern Superior... Proactive Investors (US)14:33 10-Jun-25
US FDA places clinical hold on Gilead trials testing HIV pill combination Reuters11:50 10-Jun-25
FDA Pauses Trials of Gilead HIV Combination After Safety Signal Bloomberg Law11:34 10-Jun-25
Gilead shares fall after FDA places clinical hold on HIV treatment trials Proactive Investors (US)10:29 10-Jun-25

      
            
      
    view more headlines
   
      
      
      
8 Jul 11:02
   
Gilead Sciences

Latest News

Biotech Top Stories

Business Top Stories
